Inter Pharma Valuation
| IP Stock | THB 3.54 0.04 1.12% |
At this time, the firm appears to be overvalued. Inter Pharma Public retains a regular Real Value of 3.03 per share. The prevalent price of the firm is 3.54. Our model calculates the value of Inter Pharma Public from evaluating the firm fundamentals such as Return On Asset of 0.0524, current valuation of 4.5 B, and Return On Equity of 0.1 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Inter Pharma's price fluctuation is out of control at this time. Calculation of the real value of Inter Pharma Public is based on 3 months time horizon. Increasing Inter Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Inter Pharma's intrinsic value may or may not be the same as its current market price of 3.54, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.54 | Real 3.03 | Hype 3.54 | Naive 3.56 |
The intrinsic value of Inter Pharma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Inter Pharma's stock price.
Estimating the potential upside or downside of Inter Pharma Public helps investors to forecast how Inter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inter Pharma more accurately as focusing exclusively on Inter Pharma's fundamentals will not take into account other important factors: Inter Pharma Total Value Analysis
Inter Pharma Public is currently forecasted to have takeover price of 4.5 B with market capitalization of 5.59 B, debt of 187.06 M, and cash on hands of 153.09 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Inter Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.5 B | 5.59 B | 187.06 M | 153.09 M |
Inter Pharma Investor Information
About 47.0% of the company shares are held by company insiders. The book value of Inter Pharma was currently reported as 5.09. The company has Price/Earnings (P/E) ratio of 115.05. Inter Pharma Public last dividend was issued on the 11th of March 2021. The entity had 8:13 split on the 7th of May 2024. Based on the key measurements obtained from Inter Pharma's financial statements, Inter Pharma Public is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Inter Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inter Pharma has an asset utilization ratio of 68.47 percent. This suggests that the Company is making 0.68 for each dollar of assets. An increasing asset utilization means that Inter Pharma Public is more efficient with each dollar of assets it utilizes for everyday operations.Inter Pharma Ownership Allocation
Inter Pharma Public has a total of 372.52 Million outstanding shares. Inter Pharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Inter Pharma Profitability Analysis
The company reported the revenue of 908.63 M. Net Income was 105.22 M with profit before overhead, payroll, taxes, and interest of 413.14 M.About Inter Pharma Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Inter Pharma Public. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Inter Pharma Public based exclusively on its fundamental and basic technical indicators. By analyzing Inter Pharma's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Inter Pharma's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inter Pharma. We calculate exposure to Inter Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inter Pharma's related companies.Inter Pharma Public Company Limited develops, produces, and sells healthcare products in Thailand. The company was founded in 2006 and is headquartered in Bangkok, Thailand. INTER PHARMA is traded on Stock Exchange of Thailand in Thailand.
8 Steps to conduct Inter Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Inter Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Inter Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Inter Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Inter Pharma's revenue streams: Identify Inter Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Inter Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Inter Pharma's growth potential: Evaluate Inter Pharma's management, business model, and growth potential.
- Determine Inter Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Inter Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Inter Stock
Inter Pharma financial ratios help investors to determine whether Inter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inter with respect to the benefits of owning Inter Pharma security.